Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.88
+0.61 (7.38%)
At close: Nov 20, 2024, 4:00 PM
9.00
+0.12 (1.35%)
Pre-market: Nov 21, 2024, 7:39 AM EST
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of $481.16 million as of November 21, 2024. Its market cap has increased by 293.42% in one year.
Market Cap
481.16M
Enterprise Value
1.01B
1-Year Change
293.42%
Ranking
Category
Stock Price
$8.88
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $481.16M, an increase of 49.99%. That is a compound annual growth rate of 2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 481.20M | 286.51% |
| Dec 29, 2023 | 124.50M | -78.87% |
| Dec 30, 2022 | 589.20M | -74.81% |
| Dec 31, 2021 | 2.34B | -50.75% |
| Dec 31, 2020 | 4.75B | 70.50% |
| Dec 31, 2019 | 2.79B | -7.78% |
| Dec 31, 2018 | 3.02B | 57.00% |
| Dec 29, 2017 | 1.92B | 44.63% |
| Dec 30, 2016 | 1.33B | -14.64% |
| Dec 31, 2015 | 1.56B | 52.38% |
| Dec 31, 2014 | 1.02B | 22.29% |
| Dec 31, 2013 | 836.10M | 45.38% |
| Dec 31, 2012 | 575.10M | -5.00% |
| Dec 30, 2011 | 605.40M | -25.67% |
| Dec 31, 2010 | 814.50M | 94.58% |
| Dec 31, 2009 | 418.60M | -46.42% |
| Dec 31, 2008 | 781.20M | 419.07% |
| Dec 31, 2007 | 150.50M | -50.82% |
| Dec 29, 2006 | 306.00M | -4.61% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 470.41M |
| Alumis | 470.08M |
| Taysha Gene Therapies | 467.27M |
| Theravance Biopharma | 466.66M |
| Acelyrin | 466.51M |
| UroGen Pharma | 465.88M |
| Monte Rosa Therapeutics | 463.23M |
| Celcuity | 462.63M |